Consolidation and Volatility: How Hong Kong's Niche Market Leaders Are Rewriting Their NarrativesGlobal Report·Oct 20, 2026 at 09:16 AM03046-1.58%01536-5.66%
A Device Approval, a Frozen Stock: MicroPort NeuroTech's Long HaltGlobal Report·Oct 16, 2026 at 10:47 AM021720.00%008530.00%
Venus Medtech's state rescue: China's valve makers bet on exportsGlobal Report·Oct 9, 2026 at 10:48 AM02500-2.58%021600.00%
Weekly Recap | MP CARDIOFLOW-B this week, halted with no catalystsWeekly Review·Sep 26, 2026 at 05:12 AM021600.00%
Weekly Recap | MP CARDIOFLOW-B this week, halted throughoutWeekly Review·Sep 19, 2026 at 04:47 AM021600.00%
Weekly Recap | MP CARDIOFLOW-B this week, halted on delayed resultsWeekly Review·Sep 5, 2026 at 05:05 AM021600.00%
AI Fuels Genscript's Surge as Traditional Infrastructure Faces a Harsh RealityGlobal Report·Sep 1, 2026 at 11:32 AM00322-0.22%00535-3.13%
A Market in Transition: Shifting Capital from Tech Exits to Real-Economy RevaluationsGlobal Report·Sep 1, 2026 at 09:17 AM01372-1.44%01811+0.73%
MicroPort CardioFlow delays interim results, triggers trading suspension over lease reviewTip Ranks·Sep 1, 2026 at 01:07 AM021600.00%
MicroPort CardioFlow shares on Hong Kong Stock Exchange suspended from 9 a.m. Sept. 1PUBT·Sep 1, 2026 at 12:52 AM021600.00%
MicroPort CardioFlow delays board meeting on interim results releasePUBT·Aug 26, 2026 at 02:58 PM021600.00%
MicroPort CardioFlow names Chen Guoming CEO, replacing Zhang RuinianPUBT·Aug 26, 2026 at 02:58 PM021600.00%
MicroPort CardioFlow schedules board meeting to review interim results, consider dividendPUBT·Aug 14, 2026 at 10:43 AM021600.00%